FDA Inspection 1084868 — Minsheng Group Shaoxing Pharmaceutical Co., Ltd.
The FDA completed an inspection of Minsheng Group Shaoxing Pharmaceutical Co., Ltd. on January 25, 2019 in Shaoxing. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 25, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Shaoxing (China)